ArticleThe oncologist2021

Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%?

Elettra Merola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.